Publications by authors named "Guangzhen Lu"

Claim this Profile
A
A GLP-1 receptor agonist semaglutide attenuates cardiac microvascular injury in HFD/STZ-induced diabetic mice.
Xinye Wang, Xiaoting Wang, Hong Zhuang, Guangzhen Lu, Gang Zhao

Eur J Pharmacol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Phytochemicals in Bladder Cancer Prevention and Therapy.
Yong Xia, Ruijiao Chen, Guangzhen Lu, Changlin Li, Sen Lian

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis